Examkin

Soru

Zorluk: OrtaPreventive Care and Immunizations

A 12-year-old boy is evaluated in the pediatric office for his annual health maintenance visit. He was born full-term at 39 weeks of gestation following an uncomplicated pregnancy. His vital parameters include a temperature of 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}), heart rate of 82/min, and blood pressure of 108/68 mm Hg. The physical assessment is entirely within normal limits, and he is meeting all expected psychosocial and academic milestones. His immunization record is current. As part of comprehensive preventive care, the attending physician audits the patient's historical medical chart to verify that all age-appropriate universal screening tests were conducted. Place the following universal pediatric screening interventions in the chronological order in which they are routinely recommended to occur, starting with the earliest.

  1. 1Pulse oximetry screening for critical congenital heart disease
  2. 2Administration of an autism-specific screening questionnaire (e.g., M-CHAT-R/F)
  3. 3Objective visual acuity testing using standardized optotypes
  4. 4Universal screening for dyslipidemia using a blood lipid profile
  5. 5Universal screening for major depressive disorder using a patient self-report tool

Cevap

The correct sequence of universal pediatric screenings from earliest to most recent is: 1. Critical congenital heart disease screening (Newborn), 2. Autism-specific screening (18 months), 3. Objective visual acuity with optotypes (4 years), 4. Universal dyslipidemia screening (9-11 years), 5. Universal depression screening (12 years).
Routine well-child care involves specific screening milestones aimed at early disease detection. According to the AAP, screening for critical congenital heart disease (CCHD) using pulse oximetry is universally performed in the newborn nursery prior to discharge. Autism-specific screening using standardized questionnaires (like the M-CHAT) is explicitly recommended at the 18-month and 24-month visits. Objective visual acuity testing using optotypes (e.g., Snellen chart) begins at age 4, when children can reliably follow the testing instructions. Universal lipid screening is recommended to occur once between the ages of 9 and 11 to establish a baseline before pubertal lipid changes occur. Finally, universal screening for adolescent depression using self-report tools begins at age 12.

Adım Adım Çözüm

1
Identify the recommended age for critical congenital heart disease (CCHD) screening.
Newborn period (24-48 hours of life).
Early detection via pulse oximetry is critical before the ductus arteriosus fully closes, preventing sudden cardiovascular collapse.
2
Identify the recommended age for autism-specific screening.
First administered universally at 18 months of age.
This timing coincides with critical developmental windows for identifying deficits in social communication, allowing for early intervention.
3
Identify the recommended age for objective visual acuity testing with optotypes.
Typically begins at 4 years of age.
By age 4, most children have the cognitive development and attention span required to reliably identify standardized shapes or letters on a vision chart to detect amblyopia.
4
Identify the recommended age for universal dyslipidemia screening.
Performed between 9 and 11 years of age.
Screening is completed during this window to obtain an accurate lipid baseline before the normal physiologic lipid alterations associated with puberty occur.
5
Identify the recommended age for universal adolescent depression screening.
Begins at 12 years of age.
The incidence of major depressive disorder increases significantly during early adolescence, making this the optimal time to begin annual self-reported universal screening.

Anahtar Kavram

Universal pediatric screening timeline according to the American Academy of Pediatrics (AAP) Bright Futures guidelines.
Bu soruyu puanla

Konular

Preventive Care and Immunizations

Bu konudan daha fazla soru